Associated Papers
Neurodevelopmental Implications Underpinning Hereditary Spastic Paraplegia.
Zhi Y et al.
Cns Neuroscience & Therapeutics, 2025
39932116 (PubMed )
Supplement: CNS-31-e70260-s001.xlsx › SPG77
Adult-onset combined oxidative phosphorylation deficiency type 14 manifests as epileptic status: a new phenotype and literature review.
Zhang X et al.
Bmc Neurology, 2024
Clinical and molecular characterization of novel FARS2 variants causing neonatal mitochondrial disease.
Chen W et al.
Molecular Genetics and Metabolism, 2023
Case report: A novel FARS2 deletion and a missense variant in a child with complicated, rapidly progressive spastic paraplegia.
Panzeri E et al.
Frontiers in Genetics, 2023
Two Chinese siblings of combined oxidative phosphorylation deficiency 14 caused by compound heterozygous variants in FARS2.
Li L et al.
European Journal of Medical Research, 2022
Neuropathy-associated Fars2 deficiency affects neuronal development and potentiates neuronal apoptosis by impairing mitochondrial function.
Chen X et al.
Cell & Bioscience, 2022
Novel FARS2 variants in patients with early onset encephalopathy with or without epilepsy associated with long survival.
Barcia G et al.
European Journal of Human Genetics : Ejhg, 2021
FARS2 Mutations: More Than Two Phenotypes? A Case Report.
Hotait M et al.
Frontiers in Genetics, 2020
A patient with juvenile-onset refractory status epilepticus caused by two novel compound heterozygous mutations in FARS2 gene.
Chen Z et al.
The International Journal of Neuroscience, 2019
LoLoPicker: detecting low allelic-fraction variants from low-quality cancer samples.
Carrot-Zhang J et al.
Oncotarget, 2017
28416765 (PubMed )
Supplement: oncotarget-08-37032-s001.pdf
Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient.
Zhang J et al.
Bmc Cancer, 2013
Select a paper to view details